Clinical Trail of Transtek Glass Body Fat Analyzer
GBFA
Verify the Functions and Efficiency of Transtek Glass Body Fat Analyzer, GBF-733-W1, GBF-1012, BF-1039, BF-1041-A, GBF-950-D.
2 other identifiers
observational
50
1 country
1
Brief Summary
The clinical protocol of the clinical testing of this device:
- 1.Objective of the test: To verify the functions and efficiency of devices.
- 2.Test methods and procedures: Comparison Test.
- 3.DUT(Device Under Test): Transtek Glass Body Fat Analyzer, Model: GBF-733-W1, GBF-1012, BF-1039, BF-1041-A, and GBF-950-D.
- 4.Comparison device: Transtek Glass Body Analyzer, GBF-950 (Predicate Device).
- 5.Study endpoints: Transtek devices and the predicate device are substantial equivalence.
- 6.Statistical methodology used: Description of statistical methods.
- 7.Result: Efficiencies of Transtek devices and predicate device are in the same level.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2011
CompletedFirst Submitted
Initial submission to the registry
September 25, 2011
CompletedFirst Posted
Study publicly available on registry
September 27, 2011
CompletedSeptember 27, 2011
September 1, 2011
Same day
September 25, 2011
September 25, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Verify the accuracy of measure functions of device
Verify the functions and efficiency of these devices compare with a specified product.
8 days
Study Arms (1)
Body Analysis
Interventions
Reference Device: Transtek Glass Body Analyzer, GBF-950, accuracy: ±0.1kg and range: 0-180kg. DUT(Device Under Test): Transtek Glass Body Fat Analyzer, Model: GBF-733-W1, GBF-1012, BF-1039, BF-1041-A, and GBF-950-D.
Eligibility Criteria
The subject population included patients whose age is above 18 years old. Male or Female.
You may qualify if:
- male,female
You may not qualify if:
- below 18 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Leo Wanglead
- BTS Internationalcollaborator
Study Sites (1)
Zhongshan City People's Hospital
Zhongshan, Guangdong, 528403, China
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephen Feng, Director
Zhongshan People's Hospital, Guangdong, China
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Team leader
Study Record Dates
First Submitted
September 25, 2011
First Posted
September 27, 2011
Study Start
February 1, 2011
Primary Completion
February 1, 2011
Study Completion
February 1, 2011
Last Updated
September 27, 2011
Record last verified: 2011-09